NASDAQ · XRAY

DENTSPLY SIRONA Inc.

$13.39 +$0.46 (+3.56%) 1D Market open

Key Metrics

$2.59B
Market cap
P/E · TTM
$3.68B
Revenue · TTM
−$628.00M
Net income
EPS · TTM $-3.14
Dividend yield 4.9%
Free cash flow $104.00M
Beta · 1Y 1.41
EBITDA · TTM −$220.00M
Gross margin 48.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 3
    From its Feb 27 high, the share price fell 34%.

    Peak close $14.68 on Feb 27; trough close $9.64 on Jun 3. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Feb 27
    The stock moved +15.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27
  • Feb 6
    The stock moved +9.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.59B
Enterprise value$4.64B
Shares outstanding200.3M
52-wk range$9.41 – $16.29
Avg volume · 20D2.7M
Net cash −$2.05B
Book value / share$6.60
IndustryDental Equipment & Supplies
ExchangeNASDAQ
About DENTSPLY SIRONA Inc.
IPO dateMay 12, 1983
Employees14000

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment).

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.70
P/FCF24.91
EV/EBITDA
EV/Sales1.26
Graham №

Profitability

Gross 48.9%
Operating -15.5%
Net -17.1%
FCF 2.8%
ROE / ROIC -38.5% · -18.6%

Financial Health

Current ratio1.53
Quick ratio0.98
Debt / equity1.70
Debt / EBITDA -10.16
Net cash −$2.05B
Working capital$638.00M

Cash Flow · TTM

Operating CF $268.00M
Capex −$164.00M
Free cash flow $104.00M
Buybacks
Dividends paid $128.00M
Shareholder yield 4.9%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

0.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings